IL6 and acute respiratory distress syndrome: To further confirm the therapeutic role of CBP‐Exos in modulating the systemic inflammatory response in ALI, serum analysis showed that the levels of proinflammatory cytokines, including tumor necrosis factor‐alpha (TNF‐α) and IL‐6, were significantly reduced (Figure S4A).